AR038373A1 - Sistema de suministro osmotico - Google Patents

Sistema de suministro osmotico

Info

Publication number
AR038373A1
AR038373A1 ARP030100272A ARP030100272A AR038373A1 AR 038373 A1 AR038373 A1 AR 038373A1 AR P030100272 A ARP030100272 A AR P030100272A AR P030100272 A ARP030100272 A AR P030100272A AR 038373 A1 AR038373 A1 AR 038373A1
Authority
AR
Argentina
Prior art keywords
osmotic
supply system
single layer
weight
osmotic supply
Prior art date
Application number
ARP030100272A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR038373A1 publication Critical patent/AR038373A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe un comprimido farmacéutico osmótico que comprende un núcleo comprimido de capa sencilla rodeado por una capa permeable al agua que tiene un paso. El núcleo de capa sencilla contiene (i) un fármaco no madurador con una solubilidad por dosis menor que aproximadamente 1ml-1, (ii) aproximadamente 2,0% a aproximadamente 20% en peso de una hidroxietilcelulosa con un peso molecular medio ponderal de aproximadamente 300.000 a aproximadamente 2.000.000 y (iii) un agente osmótico.
ARP030100272A 2002-02-01 2003-01-30 Sistema de suministro osmotico AR038373A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35315102P 2002-02-01 2002-02-01

Publications (1)

Publication Number Publication Date
AR038373A1 true AR038373A1 (es) 2005-01-12

Family

ID=27663182

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100272A AR038373A1 (es) 2002-02-01 2003-01-30 Sistema de suministro osmotico

Country Status (23)

Country Link
US (1) US20030175346A1 (es)
EP (1) EP1469826B1 (es)
JP (1) JP2005518418A (es)
KR (1) KR20040083492A (es)
CN (1) CN1625388A (es)
AR (1) AR038373A1 (es)
AT (1) ATE345776T1 (es)
BR (1) BR0307320A (es)
CA (1) CA2474425A1 (es)
DE (1) DE60309832T2 (es)
ES (1) ES2277632T3 (es)
GT (1) GT200300017A (es)
MX (1) MXPA04007437A (es)
NO (1) NO20043646L (es)
NZ (1) NZ533986A (es)
PA (1) PA8565201A1 (es)
PE (1) PE20030801A1 (es)
PL (1) PL372172A1 (es)
RU (1) RU2004123623A (es)
TW (1) TW200302748A (es)
UY (1) UY27644A1 (es)
WO (1) WO2003063823A2 (es)
ZA (1) ZA200405406B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US7829507B2 (en) * 2003-09-17 2010-11-09 Halliburton Energy Services Inc. Subterranean treatment fluids comprising a degradable bridging agent and methods of treating subterranean formations
CA2588293C (en) * 2004-11-24 2013-07-02 Teva Pharmaceutical Industries Ltd. Rasagiline orally disintegrating compositions
GB2421431B (en) * 2004-12-24 2007-10-10 Aquasol Ltd Dosing systems
WO2006072878A1 (en) * 2005-01-07 2006-07-13 Ranbaxy Laboratories Limited Oral dosage forms of sertraline having controlled particle size and processes for their preparation
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
US8637080B2 (en) 2007-06-28 2014-01-28 Osmotica Kereskedelmi és Szolgáltató, KFT Rupturing controlled release device comprising a subcoat
EP2416764A4 (en) * 2009-04-09 2013-09-04 Alkermes Pharma Ireland Ltd COMPOSITION FOR ACTIVE COMPOSITION
SG176785A1 (en) 2009-06-16 2012-01-30 Pfizer Dosage forms of apixaban
IT1399240B1 (it) * 2010-03-22 2013-04-11 Trere Chimica S A S Metodo e prodotto per il trattamento di sostanze alcooliche, mosti d'uva e derivati
CN102379858B (zh) * 2011-10-12 2013-06-19 中国药科大学 一种可装载大剂量难溶性药物并促进其吸收的渗透泵片
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US64556A (en) * 1867-05-07 Improved belt-punch
US39691A (en) * 1863-08-25 Improvement in pipe-couplings
US143272A (en) * 1873-09-30 Improvement in saw-sets
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4036228A (en) * 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
US4732915A (en) * 1983-11-02 1988-03-22 Alza Corporation Process for increasing solubility of drug
US4610686A (en) * 1983-11-02 1986-09-09 Alza Corporation Controlled delivery of haloperidol by an osmotic delivery system
US4627971A (en) * 1985-04-22 1986-12-09 Alza Corporation Osmotic device with self-sealing passageway
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5698224A (en) * 1994-06-27 1997-12-16 Alza Corporation Tacrine therapy
US5736159A (en) * 1995-04-28 1998-04-07 Andrx Pharmaceuticals, Inc. Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
CA2269707C (en) * 1996-10-25 2005-08-16 Edward M. Rudnic Soluble form osmotic dose delivery system
US6361796B1 (en) * 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6485748B1 (en) * 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6156342A (en) * 1998-05-26 2000-12-05 Andex Pharmaceuticals, Inc. Controlled release oral dosage form
US20010031279A1 (en) * 1998-11-02 2001-10-18 Evangeline Cruz Controlled delivery of antidepressants
JP2000171868A (ja) * 1998-12-08 2000-06-23 Canon Inc フィルム送り装置、フィルム使用装置および光学機器
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
WO2001091716A1 (en) * 2000-05-30 2001-12-06 Add Advanced Drug Delivery Technologies Ag Peroral therapeutic system comprising glipizide
IN190699B (es) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin

Also Published As

Publication number Publication date
RU2004123623A (ru) 2005-04-20
BR0307320A (pt) 2004-12-28
ATE345776T1 (de) 2006-12-15
PE20030801A1 (es) 2003-09-19
EP1469826B1 (en) 2006-11-22
TW200302748A (en) 2003-08-16
MXPA04007437A (es) 2004-10-11
DE60309832D1 (de) 2007-01-04
KR20040083492A (ko) 2004-10-02
ZA200405406B (en) 2005-07-07
DE60309832T2 (de) 2007-10-11
NZ533986A (en) 2006-03-31
CN1625388A (zh) 2005-06-08
GT200300017A (es) 2003-09-22
WO2003063823A3 (en) 2003-12-04
ES2277632T3 (es) 2007-07-16
UY27644A1 (es) 2003-09-30
WO2003063823A2 (en) 2003-08-07
CA2474425A1 (en) 2003-08-07
PL372172A1 (en) 2005-07-11
PA8565201A1 (es) 2003-12-10
NO20043646L (no) 2004-08-31
EP1469826A2 (en) 2004-10-27
US20030175346A1 (en) 2003-09-18
JP2005518418A (ja) 2005-06-23

Similar Documents

Publication Publication Date Title
AR038373A1 (es) Sistema de suministro osmotico
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
DE60310039D1 (de) Pharmazeutische tablette
BR0015605A (pt) Composição e uso
PE20001058A1 (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial
AR065073A2 (es) Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo
DK0998916T3 (da) Lægemidler til administration til slimhinden
DE60235648D1 (de) Pharmazeutische metformintablette mit verlängerter freisetzung
AR014012A1 (es) Formula de liberacion prolongada
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
AR029509A1 (es) Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales
GT199800196A (es) Combinaciones de estatina-eter carboxialquilico.
PE20030830A1 (es) Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
AR043536A1 (es) Composicion farmaceutica que comprende acido 5-metil-2-(2´-cloro-6´-fluoroanilino)fenilacetico
AR004196A1 (es) Un metodo a alta velocidad para preparar granulos esfericos que comprende un medicamento para uso farmaceutico, granulos obtenibles mediante este metodoy una bolsita que contiene dichos granulos
AR014881A1 (es) Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprendedicho sensibilizador y dicho agente
SE0001071D0 (sv) Method of inhibiting the expression of inflammatory cytokines and chemokines
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
ES2146200T3 (es) Medicamentos inducidos peritonealmente.
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
GT200000187A (es) Un estuche de combinacion usado en el tratamiento del paludismo.
ES2151383B1 (es) Derivado de hidroquinona, sus sales de hidrocloruro agente antialergico que lo comprende y farmaco antialergico correspondiente.
UY26605A1 (es) Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina

Legal Events

Date Code Title Description
FB Suspension of granting procedure